Hi, Athene.
For what it's worth, I think that the problems with folic acid, folinic acid and glutathione (including supplements that help to build glutathione, such as NAC and whey protein) that some people experience are all separate issues. While Freddd reports having all of them, I don't believe that they necessarily go together in everyone who has one or another of them.
My current working hypothesis for these is as follows:
1. The problems with folic acid could be due to a person having inherited a slow form of the DHFR enzyme, so that they are not able to convert folic acid to tetrahydrofolate at as high a rate as normal. It has been published that people vary by a factor of five (500%) in their ability to do this. If folic acid is not converted, it enters the blood stream and competes with active forms of folate for entry into the cells. This would lower the availability of 5-methyl tetrahydrofolate in the cells, which would produce a partial methylation cycle block. Another way that folic acid could cause problems is that this conversion requires NADPH, which Dr. Cheney has found to be low in many of his ME/CFS patients. If this reaction lowers NADPH further, it will not be available to support other reactions in the methylation cycle and the folate metabolism, as well as glutathione reductase. This would cause problems in all those parts of the metabolism.
2. The problems with folinic acid could be due to a polymorphism in the MTHFS (not to be confused with MTHFR) enzyme. I suspect that Freddd has this mutation. This is the only enzyme that can convert folinic acid to another form of folate, from which it can be converted to yet others. If folinic acid builds up, it has been published that it will inhibit the SHMT reaction, and that will inhibit the production of 5-methyl tetrahydrofolate, which is the one needed by methionine synthase in the methylation cycle. It will also inhibit the formation of new RNA and DNA, for the production of new cells. This especially impacts the production of blood cells, cells lining the gut, and cells of the hair follicles, thus causing problems there especially.
3. The problems with glutathione and associated substances are likely due to an inherited mutation in the CblC complementation group (coded by the MMACHC gene), which is part of the B12 processing pathway inside the cells. If certain mutations are present in this gene, the result will be that glutathione will bind B12 as glutathionylcobalamin, and the cells will not be able to make use of it. This will then cause a partial methylation cycle block and a lowering of the feeding of fuel to the Krebs cycle in the mitochondria, lowering the ATP production of the cells. I think that Freddd has this one, too. Associated with this type of mutation is also an inability to use cyanocobalamin or hydroxocobalamin as one's B12 source, because the Cblc complementation group is responsible for preparing these for conversion to the coenzyme forms of B12 (methyl B12 and adenosyl B12). People who have this type of mutation, which I think Freddd has, need to put large amounts of these two coenzyme B12 forms into their blood, either sublingually or by injection, in order to force enough of them to diffuse directly into the cells to be used without further processing inside the cells.
I should also note that if a person is particularly low in NADPH, I suspect that they will also have problems with glutathione and related substances, because they will not be able to reduce glutathione readily after it becomes oxidized. This will cause a buildup of oxidized glutathione and thus shift the redox potential in the oxidizing direction, worsening the oxidative stress and exacerbating all the associated symptoms. I suspect that this problem would show up more slowly than the problem I just described involving Cblc.
So my point is that I believe that a given person who has ME/CFS may have one of these issues without having all of them, and as far as I can tell, most of the people don't have any of them. I'm basing this on the results of the clinical study that Dr. Nathan and I carried out, in which we used folic acid, folinic acid and hydroxocobalamin, and about two-thirds of the people had significant improvement. It is certainly possible that at least some of the other third had one or more of these problems, but there was also evidence that some had biotoxin illnesses, and this could have prevented their recovery as well.
I'm glad that Freddd is attempting to get more information about how people are affected by these supplements. This could end up helping people who do not respond well to the simplified treatment protocol that I have suggested. If we can understand why, we might be able to do some relatively inexpensive genetic characterization, such as with
www.23andme, and be able to determine what protocol would work best for different people.
So I hope that people will try to distinguish which of these issues they actually have, and not assume that if they have one of them, they must have all of them.
Best regards,
Rich